Home » Topics » BioWorld Science

BioWorld Science
RSS

Galafold launched in Japan for Fabry disease

May 30, 2018

EMA validates MAA for Inbrija

May 30, 2018

Genentech and Roche patent RORC ligands

May 30, 2018

New nicotinic alpha7 receptor PAMs presented by Merck & Co.

May 30, 2018

Russian investigators patent ciprofloxacin derivatives

May 30, 2018

Auckland Uniservices divulges CSF1R inhibitors

May 30, 2018

U.S. researchers patent ITGA4 antagonists

May 30, 2018

FDA accepts NDA for larotrectinib and grants priority review

May 30, 2018

FDA accepts NDA and grants priority review status for Firdapse

May 30, 2018

European Commission grants authorization to Rubraca for recurrent ovarian cancer

May 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...